<p>The United States Food and Drug Administration (FDA) has imposed an import alert, effectively a ban, on generic drugmaker Sun Pharmaceutical Industries plant in Gujarat.<br/><br/>An "import alert" results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices, according to the FDA website.<br/><br/>A spokesman for Sun, India's biggest drugmaker by market value, was not available for comment.<br/><br/><div id="checked" style="display: none"><div id="adslotNativeVideo" style="text-align:center; padding-bottom:20px;"><script>googletag.cmd.push(function() { googletag.display("adslotNativeVideo"); });</script></div></div>The plant in Karkhadi in Gujarat makes both drug ingredients and formulations, according to Sun's 2013 annual report.<br/><br/><a class="showFilePanel" href="javascript:void(0);"><div class="comment_story"><span><em class="ndtv-detailp-comments-count"></em></span></div></a>The company's shares fell as much as 6.4 per cent today.</p>
<p>................................ Advertisement ................................</p>
<p>................................ Advertisement ................................</p>
<p>................................ Advertisement ................................</p>
